23 results
F-4
EX-10.11
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
and training meetings. Some of these meetings may involve overseas travel. In addition, you will be required to consider all relevant papers before … will be provided to you separately.
TRAINING
On an ongoing basis, and further to the annual evaluation process, the Company will arrange for you
F-4
EX-10.10
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
evaluation process and updating and training meetings. Some of these meetings may involve overseas travel. In addition, you will be required to consider all … . A copy of the current share dealing code adopted by the Company will be provided to you separately.
TRAINING
On an ongoing basis, and further
F-4
EX-10.12
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
evaluation process and updating and training meetings. Some of these meetings may involve overseas travel. In addition, you will be required to consider … securities. A copy of the current share dealing code adopted by the Company will be provided to you separately.
TRAINING
On an ongoing basis, and further
F-4
EX-10.13
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
evaluation process and updating and training meetings. Some of these meetings may involve overseas travel. In addition, you will be required to consider all … . A copy of the current share dealing code adopted by the Company will be provided to you separately.
TRAINING
On an ongoing basis, and further
F-4
EX-10.9
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
evaluation process and updating and training meetings. Some of these meetings may involve overseas travel. In addition, you will be required to consider … securities. A copy of the current share dealing code adopted by the Company will be provided to you separately.
TRAINING
On an ongoing basis, and further
6-K
42x15 ms2vo594
16 Jul 19
Current report (foreign)
8:21am
10-K
EX-19.1
82fs500xhr0c
27 Mar 24
Annual report
5:20pm
10-K
l5v8iw4ef5lx5z qfpg
27 Mar 24
Annual report
5:20pm
F-4
EX-10.21
bkfs5c 9xsu9
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.22
2fqn 3no9gp1l
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.20
0jdv1pxd
25 Jan 19
Registration of securities (foreign)
12:00am
20-F
dm8p1m
29 Apr 19
Annual report (foreign)
4:59pm
F-1/A
m5u0i12y7r13o
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
F-1/A
a2f0bgitoyfu653r
12 Mar 20
Registration statement (foreign) (amended)
5:15pm